GR 46611
Names
Biological Activity
[Description]:
GR-46611 is a 5-HT1D receptor agonist. GR-46611 can be used in the research of bladder hyperactivity, leukemia[1][3].
[Related Catalog]:
[Target]
5-HT1D Receptor
[In Vitro]
GR-46611 (1 μM, 48 h) induces CEM cell proliferation[2]. Cell Proliferation Assay[2] Cell Line: CEM cells (human T lymphoblastic leukemia cell line) Concentration: 1 μM Incubation Time: 48 h Result: Induced a significant increase in cell proliferation by 37.0%.
[In Vivo]
GR-46611 (1 mg/kg, i.p. ) significantly improves survival of Dravet syndrome (DS) mice[1]. GR-46611 (0.03-300 μg/kg, i.v.) increases threshold volume, bladder capacity, and residual volume in chronic spinal cord injury (SCI) cats[3]. GR46611 (3-30 mg/kg, s.c.) causes a dose-related decrease in rectal temperature in the adult guinea-pig[4]. Animal Model: Dravet syndrome (DS) mice[1] Dosage: 0.01, 0.1 and 1 mg/kg Administration: Intraperitoneal injection (i.p.) Result: Improved survival relative to vehicle treated controls with 89% surviving rate.
[References]
Chemical & Physical Properties
[ Density]:
1.168g/cm3
[ Boiling Point ]:
645.9ºC at 760mmHg
[ Molecular Formula ]:
C23H27N3O2
[ Molecular Weight ]:
377.47900
[ Flash Point ]:
344.4ºC
[ Exact Mass ]:
377.21000
[ PSA ]:
57.36000
[ LogP ]:
4.00110
[ Vapour Pressure ]:
1.43E-16mmHg at 25°C
[ Index of Refraction ]:
1.639
[ Storage condition ]:
-20°C
MSDS
Safety Information
[ Hazard Codes ]:
Xi: Irritant;
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S26